PHASERX INC by PhaseRx, Inc. (PZRXQ)

About PHASERX INC by PhaseRx, Inc. (PZRXQ)

PhaseRx, Inc. operates as a bio pharmaceutical company that develops a portfolio of mRNA products to correct inherited, life-threatening liver diseases in children. Its product portfolio targets the three urea cycle disorders ornithine transcarbamylase deficiency, argininosuccinate lyase deficiency and argininosuccinate synthetase deficiency. The company was founded by Robert W. Overell, Patrick S. Stayton, Allan S. Hoffman, Oliver W. Press and Paul H. Johnson on March 9, 2006 and is headquartered in Seattle, WA.

PHASERX INC by PhaseRx, Inc. News